IL23A and psoriasis: A significant study conducted by Leslie van der Fits and colleagues in 2009 revealed that the knockout of both IL-23 and IL-17 nearly entirely abrogated imiquimod-induced psoriasis-like skin inflammation in murine models, thereby demonstrating that this inflammation is predominantly mediated by the IL-23/IL-17 axis [25].